Iron as a cause of Parkinson disease - a myth or a well established hypothesis?

被引:28
作者
Friedman, Andrzej [1 ]
Galazka-Friedman, Jolanta [2 ]
Koziorowski, Dariusz [1 ]
机构
[1] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[2] Warsaw Univ Technol, Fac Phys, Warsaw, Poland
关键词
Iron; Oxidative stress; Parkinson disease; SUBSTANTIA-NIGRA; ALZHEIMERS-DISEASE; FERRITIN; BRAIN; SPECTROSCOPY; NEOCORTEX; COMPLEX; METALS; ELISA;
D O I
10.1016/S1353-8020(09)70817-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Iron is considered to be a possible trigger of oxidative stress leading to neurodegeneration. This mechanism of neuronal death is proposed as a cause of Parkinson disease. Although most of researchers agree with this, controversies remain regarding the amounts of iron needed for this process. According to non destructive methods of assessment of the concentration of the total iron in substantia nigra, there is no difference between PD and control. However there is no need for an increase of the total iron in parkinsonian SN to trigger the oxidative stress but only of the non-ferritin bound labile iron. Our recent studies suggest an increase of this iron in PD SN. This finding corresponds well to a decrease of L-ferritin concentration in parkinsonian SN and also to a difference of the size of iron core of ferritin between PD and control SN. The significance of these finding will be discussed. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S212 / S214
页数:3
相关论文
共 28 条
[1]   DOES IRON PLAY A ROLE IN PARKINSONS-DISEASE [J].
BAUMINGER, ER ;
BARCIKOWSKA, M ;
FRIEDMAN, A ;
GALAZKAFRIEDMAN, J ;
HECHEL, D ;
NOWIK, I .
HYPERFINE INTERACTIONS, 1994, 91 (1-4) :853-857
[2]  
CONNOR JR, 1995, J NEUROCHEM, V65, P717
[3]   Evidence of oxidative stress in the neocortex in incidental Lewy body disease [J].
Dalfó, E ;
Portero-Otín, M ;
Ayala, V ;
Martínez, A ;
Pamplona, R ;
Ferrer, I .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (09) :816-830
[4]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[5]   STUDIES ON PARKINSONS DISEASE INCLUDING X-RAY FLUORESCENT SPECTROSCOPY OF FORMALIN FIXED BRAIN TISSUE [J].
EARLE, KM .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1968, 27 (01) :1-+
[6]  
Friedman Andrzej, 2007, Handb Clin Neurol, V83, P493, DOI 10.1016/S0072-9752(07)83023-5
[7]   Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders [J].
Fukae, J ;
Takanashi, M ;
Kubo, S ;
Nishioka, K ;
Nakabeppu, Y ;
Mori, H ;
Mizuno, Y ;
Hattori, N .
ACTA NEUROPATHOLOGICA, 2005, 109 (03) :256-262
[8]   Mossbauer spectroscopy and ELISA studies reveal differences between. Parkinson's disease and control substantia nigra [J].
Galazka-Friedman, J ;
Bauminger, ER ;
Koziorowski, D ;
Friedman, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1688 (02) :130-136
[9]   Iron in Parkinson's disease revisited [J].
Galazka-Friedman, J ;
Bauminger, ER ;
Friedman, A .
HYPERFINE INTERACTIONS, 2002, 141 (1-4) :267-271
[10]   Iron in the brain [J].
Galazka-Friedman, Jolanta ;
Friedman, Andrzej ;
Bauminger, Erika R. .
ISIAME 2008, 2009, :31-+